Key statistics dashboard for NanoVibronix, Inc. (NAOV). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain.
Stock Data
| Price | $1.90 |
| Market Cap | $2M |
| Beta | 2.06 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.07 |
| Price / Book | 0.38 |
| P/S | 0.79 |
| P/FCF | -0.13 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -26.06% |
| EBIT Margin | 321.50% |
| EBITDA Margin | 75.29% |
| Operating Margin | -1362.72% |
| Net Margin | -1259.55% |
Financial Health
| Current Ratio | 0.66 |
| Quick Ratio | 0.31 |
| Cash Ratio | 0.15 |
| Debt / Equity | 0.01 |
| Debt / Assets | 0.60% |
| Interest Coverage | 96.14 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -4.72 |
Per-Share Data
| Revenue per share | 0.31 |
| Book Value per share | 5.00 |
| Cash per share | 0.18 |
| FCF per share | -1.91 |
| Tangible Book Value per share | -0.37 |
| Dividend per share | 0.00 |
Explore sector: Healthcare · Medical - Devices
More sections of NAOV: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks